Volume 12, Number 3—March 2006
Medication Sales and Syndromic Surveillance, France
|Cough suppressant with another medication*†|
|Cough suppressant with bronchial-pulmonary antimicrobial drug*†|
|Topical nose cream*†|
|General rhinosinusitis preparation*|
|Other antimicrobial agent*|
|Rhinocorticoids without antiinflammatory agent*|
|Tetracycline in association with another medication*|
|Vitamin C only*|
|Pharyngeal antiinflammatory decongestant|
|Antiviral except anti-HIV|
|Cough suppressant only|
|Nasal antiinflammatory except corticoids|
|Vitamin C in association with another medication|
*Significant (p<0.05) medication classes that were included in the 1-, 2-, and 3-week-ahead national predictive models.
†Medication classes included in >50% of regional predictive models.
1Both authors contributed equally to this research.
Page created: January 27, 2012
Page updated: January 27, 2012
Page reviewed: January 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.